Overview
Malignant peripheral neuroectodermal tumors (MPNTs) are aggressive neoplasms primarily affecting children and adolescents, often resembling Ewing's sarcoma histologically but distinguished by specific immunohistochemical markers and ultrastructural features. 1Diagnosis
Histological Features: Resemble Ewing's sarcoma with minor differences; may include ganglion cells and Flexner rosettes. 1
Immunohistochemistry: Positive staining for neuron-specific enolase (NSE) in most cases; variable positivity for protein S-100, vimentin, neurofilaments, and GFAP. 1
Electron Microscopy: Useful for distinguishing from Ewing's sarcoma by identifying neurosecretory granules and other ultrastructural characteristics. 1Management
Primary Treatment: Typically involves multimodal therapy including surgery, chemotherapy, and radiation therapy, though specific drug classes and doses are not detailed in the provided abstracts. 1
Chemotherapy Regimens: Not specified in the abstracts; standard regimens for sarcomas may be considered pending further guidance. 1
Radiation Therapy: Often used in conjunction with surgery and chemotherapy, particularly for unresectable or metastatic disease. 1Special Populations
Pediatrics: MPNTs predominantly affect children and adolescents, with a mean age of 10 years. 1
Prognosis: Poor in most cases, with survival outcomes varying widely among patients. 1Key Recommendations
Distinguish MPNTs from Ewing's sarcoma using NSE staining and electron microscopy findings. (Evidence: Moderate) 1
Employ multimodal treatment strategies including surgery, chemotherapy, and radiation therapy for optimal management. (Evidence: Expert opinion) 1
Monitor pediatric patients closely due to the aggressive nature and poor prognosis associated with MPNTs. (Evidence: Moderate) 1References
1 Schmidt D, Harms D, Burdach S. Malignant peripheral neuroectodermal tumours of childhood and adolescence. Virchows Archiv. A, Pathological anatomy and histopathology 1985. link